TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 48 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,575 | +1115.9% | 3,663,104 | +154.2% | 0.50% | +1553.3% |
| Q2 2023 | $952 | -17.1% | 1,440,882 | 0.0% | 0.03% | -55.9% |
| Q1 2023 | $1,149 | -64.7% | 1,440,882 | 0.0% | 0.07% | -62.6% |
| Q4 2022 | $3,256 | -99.8% | 1,440,882 | +38.4% | 0.18% | +111.6% |
| Q3 2022 | $2,009,000 | -48.1% | 1,040,882 | 0.0% | 0.09% | -58.5% |
| Q2 2022 | $3,872,000 | -42.9% | 1,040,882 | 0.0% | 0.21% | -27.1% |
| Q1 2022 | $6,787,000 | -44.0% | 1,040,882 | 0.0% | 0.28% | -13.7% |
| Q4 2021 | $12,126,000 | -37.4% | 1,040,882 | 0.0% | 0.33% | -24.2% |
| Q3 2021 | $19,381,000 | -12.2% | 1,040,882 | 0.0% | 0.43% | -3.1% |
| Q2 2021 | $22,067,000 | +4.4% | 1,040,882 | 0.0% | 0.45% | +20.1% |
| Q1 2021 | $21,130,000 | -23.5% | 1,040,882 | 0.0% | 0.37% | -37.1% |
| Q4 2020 | $27,625,000 | +8.1% | 1,040,882 | -8.8% | 0.59% | -4.4% |
| Q3 2020 | $25,556,000 | – | 1,140,882 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |